本文選題：支氣管哮喘 + 氣道反應(yīng)性��； 參考：《中國中西醫(yī)結(jié)合雜志》2014年05期

【摘要】：正支氣管哮喘是由多種細胞和細胞組合參與的氣道慢性炎癥性疾病。這種慢性炎癥導(dǎo)致氣道反應(yīng)性增加,從而產(chǎn)生喘息、氣急、胸悶、咳嗽的反復(fù)發(fā)作,并且常在夜間或凌晨發(fā)作。這種發(fā)作通常和廣泛多變的可逆性氣流受限有關(guān),可自行緩解或經(jīng)治療后緩解[1]。盡管近十年來西醫(yī)按照GINA指南[2]用藥方法,即使用糖皮質(zhì)激素與長效β2受體激動劑結(jié)合的吸入粉劑,取得很大進展,然而對糖皮質(zhì)激素依賴的難治性哮喘
[Abstract]:Positive bronchial asthma is a chronic inflammatory disease of the airway that involves a variety of cells and cell combinations. This chronic inflammation leads to increased airway responsiveness, resulting in recurrent episodes of wheezing, shortness of breath, chest tightness, coughing, and often occurring at night or in the wee hours. This attack is usually associated with a wide variety of reversible airflow limitations, which can be alleviated either spontaneously or after treatment [1]. Although Western medicine has made great progress in the past decade in accordance with the GINA guidelines, even inhaled powders that combine glucocorticoids with long-acting 尾 _ 2-agonists, refractory asthma is glucocorticoid-dependent.
【作者單位】： 中國中醫(yī)科學(xué)院廣安門醫(yī)院呼吸科;
【分類號】：R562.25

【相似文獻】

相關(guān)期刊論文 前10條

1 戴蘭英;中西醫(yī)結(jié)合治療支氣管哮喘43例[J];廣西中醫(yī)學(xué)院學(xué)報;1999年02期

2 劉美玲;中西醫(yī)結(jié)合治療兒童發(fā)作期支氣管哮喘療效觀察[J];國際醫(yī)藥衛(wèi)生導(dǎo)報;2003年18期

3 陳藝軍;;中西醫(yī)結(jié)合治療支氣管哮喘50例[J];中國中醫(yī)急癥;2008年04期

4 沈觀樂;中西醫(yī)結(jié)合治療支氣管哮喘的體會[J];深圳中西醫(yī)結(jié)合雜志;1996年02期

5 林熙,黃河清,李希;中西醫(yī)結(jié)合治療支氣管哮喘急性發(fā)作30例[J];福建中醫(yī)學(xué)院學(xué)報;2003年04期

6 李衛(wèi)山;中西醫(yī)結(jié)合治療支氣管哮喘[J];湖北中醫(yī)雜志;1999年01期

7 趙，

本文編號：1830285